[250 Pages Report] Newly-released Laryngeal Mask Market analysis report by Future Market Insights shows that global sales of Laryngeal Mask Market in 2021 was held at US$ 656.4 Million. With 7.9%, theprojectedmarketgrowthduring2022 to 2032 is expected to be significantly higher than the historical growth.
Disposable Laryngeal Masks is expected to be the highest revenue generating segment, projected to grow at a CAGR of over 7.9% during 2022 to 2032.
Attributes
Details
Laryngeal Mask Market CAGR (2022 to 2032)
7.9%
Laryngeal Mask Market Size (2022)
US$ 656.4 million
Laryngeal Mask Market Size (2032)
US$ 1.5 billion
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Revenue Of Laryngeal Mask Market From 2017 To 2021 Compared To Demand Outlook For 2022 To 2032
According to the Laryngeal Mask Market study conducted by Future Market Insights, a market research and competitive intelligence company, the market value of the Laryngeal Mask Market rose at a CAGR of roughly 7.1% from 2017 to 2021.
The market for laryngeal masks is expected to expand in conjunction with technical advances, such as the use of mechanical ventilation in suitably fasting patients while limiting the inspiratory forces imposed. When compared to first-generation LMAs, second-generation devices may reduce leak and restrict stomach insufflation. Moreover, throughout the projected period, increased demand for airway laryngeal masks are likely to drive the demand.
The lower cost per patient with the usage of the laryngeal masks contributes to their increasing popularity. Furthermore, the widespread availability of reusable laryngeal masks drives the revenue. Besides, their simplicity of usage and lesser requirement of sanitization, maintenance, less space consuming characteristic and being cost effective increases their utility.
What Factors Are Propelling Laryngeal Mask Demand?
In the coming years, the overwhelming numbers of surgical operations for the management of chronic disorders such as chronic bronchitis and asthma is predicted to fuel consumer demand for laryngeal mask. A significant increase in the worldwide frequency of respiratory ailments such as chronic obstructive pulmonary disease, and acute respiratory distress syndrome is expected to offer growth prospects over the projected timeframe.
Similarly, higher supply for airway ventilated laryngeal masks is expected to raise demand during the forecast period. Disposable medical equipment are in high demand in critical care units such as Intensive care unit (ICU) ortrauma centers which has been consequently pushing the demand for laryngeal mask.
Furthermore, the introduction of low-cost laryngeal masks and growing market penetration efforts by key competitors in different regions, is expected to boost the revenue for laryngeal mask market. Furthermore, the increased frequency of chronic conditions requiring anaesthetic operations is pushing the demand for laryngeal masks.
As per the Healthcare Insurance Reciprocal of Canada (HIROC) and the Canadian Medical Protective Association (CMPA) medico-legal, about 1 Mn operations are conducted each year, drives the laryngeal mask demand.
Find your sweet spots for generating winning opportunities in this market.
Which Category Of The Laryngeal Mask Market Grew The Fastest, Based On End Use?
Based on end-user, hospitals and clinics held the largest revenue share of over 60.3% in the market for laryngeal masks in 2020. Mask for the larynx airway is extremely useful in pre-hospital situations, for treating problematic airways, apart from the patients suffering from cardiac arrest.
Outside of the hospital, an LMA can be implanted for effective airway control until a permanent airway can be established. Due to the ease of accessibility and usage of attractive compensation schemes such as Medicare and Blue Cross Blue Shield, the segment will maintain its leading position during the predicted period. As a consequence, the worldwide market for laryngeal masks is predicted to grow at a fast pace in the coming years.
Which Region Is Projected To Offer The Largest Opportunity For Laryngeal Mask Market?
North America is likely to dominate the laryngeal mask market in the future years, owing to factors such as enhanced healthcare infrastructure and increase in the incidence of respiratory ailments like asthma. In addition, growing anaesthetic usage during surgeries is further driving the demand for laryngeal masks. Market growth is also attributed to standard regulatory regulations such as the compulsion to use masks during Covid in the region.
In contrast, the market in Asia Pacific is predicted to develop at the faster rate as compared to other regions over the forthcoming decade. The growth in revenue can be attributed to various factors including increase in the number of elderly population, and active involvement of industry participants like Medtronic Plc, Teleflex Inc., Intersurgical Ltd. towards increasing focus on the region's emerging countries.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Country-Wise Analysis
Which Country Lies at the CenterStage for Laryngeal Mask Market Revenue?
The United States is a large global market for laryngeal masks. Over the forecast period, the laryngeal mask market in the United States is expected to witness significant boom. The country’s laryngeal mask market is fueled by growing elderly population and chronic illnesses.
Category-Wise Insights
Why Disposable Laryngeal Masks is projected to Witness Fastest Growth among Laryngeal Mask Type?
During 2022-2032, disposable laryngeal masks market is expected to increase at a CAGR of about 7.9%. It provides patients with a pleasant airway while also removing the risk of disease transmission because it is not reused.
Furthermore, under nitrous oxide anaesthesia, laryngeal masks have a rather steady intracuff pressure. The disposable laryngeal mask is designed to be used as an alternative to a facemask for attaining and maintaining airway control in patients during normal and emergency anaesthetic treatments.
The decreased cost per patient associated with the usage of these masks can be attributable to their greater utilisation. Furthermore, owing to their cost effectiveness, their volume sales is on surge. These factors are likely to attract developing enterprises with limited capital resources to enter the market.
Why Laryngeal Masks Market garner high revenues through adults segment?
Revenue through Adults segment is expected to command significant revenue as well as a CAGR of approximately 8.1% in the Laryngeal Mask Market over the projection period. Because of the growing number of operations and the high incidence of chronic illnesses amongst adulthood, the segment is likely continue to grow at a constant CAGR.
Based on World Center for Environmental Research and Public Health, more than half of all Americans have chronic illness. The impact of chronic diseases on the laryngeal mask business in the near future is depicted to boost the market.
What is the impact of Covid-19 on Laryngeal Mask Market?
The COVID-19 pandemic is still harming many businesses' growth, and the outbreak's early signs are varied. Laryngeal masks were seen as a substitute to mask anesthetic and endotracheal intubation for surgical operations and the treatments of difficult airways.
Anaesthetists are more susceptible to infection when they perform aerosol-generating airway operations on a regular basis. This led in a slow adoption of laryngeal covers during the epidemic. Several anaesthetic essential management approaches had also been suggested due to the coronavirus epidemic. Some essential management approaches included safeguarding clinical staff and reducing aerosol emission.
Competitive Analysis
The industry for laryngeal masks is being driven by a rise in medical procedures coupled with an expansion in disposable mask demands. Several mid-size and smaller enterprises are growing their market presence by offering laryngeal masks at cheaper pricing.
Some of the recent developments of key Laryngeal Mask providers are as follows:
In February 2021, Ambu A/S announced to expand its single-use endoscopy contracts with two major US Group Purchasing Organizations.
In May 2019, Ambu A/S signed a strategic partnership with Cook Medical, under which Cook Medical would distribute Ambu's products in the United States.
Similarly, recent developments related to companies Laryngeal Mask services have been tracked by the team at Future Market Insights, which are available in the full report.
Laryngeal Mask Market Report Scope
Attribute
Details
Forecast Period
2022 to 2032
Historical Data Available for
2017 to 2021
Market Analysis
US$ Million for Value
Key Regions Covered
North America, Latin America, Europe, Asia Pacific, Middle East & Africa
Key Countries Covered
United States, Canada, Brazil, Mexico, Germany, UK, France, Spain, Italy, Russia, China, Japan, South Korea, India, Australia, South Africa, Saudi Arabia, UAE and Israel.
Key Market Segments Covered
Product Type, Patient, End Uses, Region
Key Companies Profiled
Ambu A/S
BLS Systems
Medtronic
Hsiner Co. Ltd
Thermo Fisher
Cardinal Health
Smiths Group plc
Intersurgical
Teleflex Incorporated
Ferno
Pricing
Available upon Request
Market Segments Covered In Laryngeal Mask Market Analysis
By Product Type:
Reusable Laryngeal Masks
Disposable Laryngeal Masks
By Patient:
Children
Adult
Geriatric
By End-use:
Hospitals & Clinics
Ambulatory Surgical Centers
By Region:
North America
Latin America
Europe
APAC
MEA
Frequently Asked Questions
How much is the current worth of the Laryngeal Mask Market?
The global Laryngeal Mask Market is worth more than US$ 656.4 Mn at present.
What is the sales forecast for Laryngeal Mask Market?
Value of Laryngeal Mask Market are projected to increase at a CAGR of around 7.9% during 2022 – 2032.
What was the last 5 year’s market CAGR?
Value of Laryngeal Mask Market increased at a CAGR of around 7.1% during 2017 – 2021.
What is a key trend shaping the growth of the market for Laryngeal Mask Market?
The rising number of surgical operations, technical advancements, the prevalence of chronic respiratory disorders, and the ageing population are all propelling the laryngeal mask market forward.
At what percentage is sales of Laryngeal Mask Market going to register growth in China?
The market for Laryngeal Mask Market in China is projected to expand at a CAGR of around 9.6% during 2022 – 2032.
What do statistics for South Korea and Japan reveal?
While the market in South Korea is expected to grow at nearly 8.3%, the market in Japan is projected to register a CAGR of nearly 10.1% during 2022 - 2032.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
4. Global Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2022-2032
5.3.1. Reusable Laryngeal Masks
5.3.2. Disposable Laryngeal Masks
5.3.3. Laparoscopic Diagnostic Procedures
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021
5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032
6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Patient
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Patient, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Patient, 2022-2032
6.3.1. Children
6.3.2. Adult
6.3.3. Geriatric
6.4. Y-o-Y Growth Trend Analysis By Patient, 2017-2021
6.5. Absolute $ Opportunity Analysis By Patient, 2022-2032
7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By End Use
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) Analysis By End Use, 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End Use, 2022-2032
7.3.1. Hositals and Clinics
7.3.2. Ambulatiry Surgical Centers
7.4. Y-o-Y Growth Trend Analysis By End Use, 2017-2021
7.5. Absolute $ Opportunity Analysis By End Use, 2022-2032
8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. By Product Type
9.2.3. By Patient
9.2.4. By End Use
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Patient
9.3.4. By End Use
9.4. Key Takeaways
10. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product Type
10.2.3. By Patient
10.2.4. By End Use
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Patient
10.3.4. By End Use
10.4. Key Takeaways
11. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. Italy
11.2.1.3. France
11.2.1.4. U.K.
11.2.1.5. Spain
11.2.1.6. Russia
11.2.1.7. BENELUX
11.2.1.8. Rest of Europe
11.2.2. By Product Type
11.2.3. By Patient
11.2.4. By End Use
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Patient
11.3.4. By End Use
11.4. Key Takeaways
12. Asia Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.1.4. India
12.2.1.5. Rest of Asia Pacific
12.2.2. By Product Type
12.2.3. By Patient
12.2.4. By End Use
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Patient
12.3.4. By End Use
12.4. Key Takeaways
13. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. GCC
13.2.1.2. Rest of MEA
13.2.2. By Product Type
13.2.3. By Patient
13.2.4. By End Use
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By Patient
13.3.4. By End Use
13.4. Key Takeaways
14. Key Countries Market Analysis
14.1. U.S.
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2021
14.1.2.1. By Product Type
14.1.2.2. By Patient
14.1.2.3. By End Use
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2021
14.2.2.1. By Product Type
14.2.2.2. By Patient
14.2.2.3. By End Use
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2021
14.3.2.1. By Product Type
14.3.2.2. By Patient
14.3.2.3. By End Use
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2021
14.4.2.1. By Product Type
14.4.2.2. By Patient
14.4.2.3. By End Use
14.5. Argentina
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2021
14.5.2.1. By Product Type
14.5.2.2. By Patient
14.5.2.3. By End Use
14.6. Germany
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2021
14.6.2.1. By Product Type
14.6.2.2. By Patient
14.6.2.3. By End Use
14.7. Italy
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2021
14.7.2.1. By Product Type
14.7.2.2. By Patient
14.7.2.3. By End Use
14.8. France
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2021
14.8.2.1. By Product Type
14.8.2.2. By Patient
14.8.2.3. By End Use
14.9. U.K.
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2021
14.9.2.1. By Product Type
14.9.2.2. By Patient
14.9.2.3. By End Use
14.10. Spain
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2021
14.10.2.1. By Product Type
14.10.2.2. By Patient
14.10.2.3. By End Use
14.11. Russia
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2021
14.11.2.1. By Product Type
14.11.2.2. By Patient
14.11.2.3. By End Use
14.12. BENELUX
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2021
14.12.2.1. By Product Type
14.12.2.2. By Patient
14.12.2.3. By End Use
14.13. China
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2021
14.13.2.1. By Product Type
14.13.2.2. By Patient
14.13.2.3. By End Use
14.14. Japan
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2021
14.14.2.1. By Product Type
14.14.2.2. By Patient
14.14.2.3. By End Use
14.15. South Korea
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2021
14.15.2.1. By Product Type
14.15.2.2. By Patient
14.15.2.3. By End Use
14.16. India
14.16.1. Pricing Analysis
14.16.2. Market Share Analysis, 2021
14.16.2.1. By Product Type
14.16.2.2. By Patient
14.16.2.3. By End Use
14.17. GCC Countries
14.17.1. Pricing Analysis
14.17.2. Market Share Analysis, 2021
14.17.2.1. By Product Type
14.17.2.2. By Patient
14.17.2.3. By End Use
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Product Type
15.3.3. By Patient
15.3.4. By End Use
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Ambu A/S
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segment
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.1.5.2. Product Strategy
16.1.2. BLS Systems
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segment
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.2.5.2. Product Strategy
16.1.3. Medtronic
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segment
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.3.5.2. Product Strategy
16.1.4. Hsiner Co. Ltd.
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segment
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.4.5.2. Product Strategy
16.1.5. Thermo Fisher
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segment
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.5.5.2. Product Strategy
16.1.6. Cardinal Health
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segment
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.6.5.2. Product Strategy
16.1.7. Smiths Group plc
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segment
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.7.5.2. Product Strategy
16.1.8. Intersurgical
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segment
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.8.5.2. Product Strategy
16.1.9. Telefelx Incorporated
16.1.9.1. Overview
16.1.9.2. Product Portfolio
16.1.9.3. Profitability by Market Segment
16.1.9.4. Sales Footprint
16.1.9.5. Strategy Overview
16.1.9.5.1. Marketing Strategy
16.1.9.5.2. Product Strategy
16.1.10. Ferno
16.1.10.1. Overview
16.1.10.2. Product Portfolio
16.1.10.3. Profitability by Market Segment
16.1.10.4. Sales Footprint
16.1.10.5. Strategy Overview
16.1.10.5.1. Marketing Strategy
16.1.10.5.2. Product Strategy
17. Assumptions & Acronyms Used18. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 01: Global Market Value (US$ Mn) Forecast by Region, 2017-2032
Table 02: Global Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 03: Global Market Value (US$ Mn) Forecast by Patient, 2017-2032
Table 04: Global Market Value (US$ Mn) Forecast by End Use, 2017-2032
Table 05: North America Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 06: North America Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 07: North America Market Value (US$ Mn) Forecast by Patient, 2017-2032
Table 08: North America Market Value (US$ Mn) Forecast by End Use, 2017-2032
Table 09: Latin America Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 10: Latin America Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 11: Latin America Market Value (US$ Mn) Forecast by Patient, 2017-2032
Table 12: Latin America Market Value (US$ Mn) Forecast by End Use, 2017-2032
Table 13: Europe Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 14: Europe Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 15: Europe Market Value (US$ Mn) Forecast by Patient, 2017-2032
Table 16: Europe Market Value (US$ Mn) Forecast by End Use, 2017-2032
Table 17: Asia Pacific Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 18: Asia Pacific Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 19: Asia Pacific Market Value (US$ Mn) Forecast by Patient, 2017-2032
Table 20: Asia Pacific Market Value (US$ Mn) Forecast by End Use, 2017-2032
Table 21: MEA Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 22: MEA Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 23: MEA Market Value (US$ Mn) Forecast by Patient, 2017-2032
Table 24: MEA Market Value (US$ Mn) Forecast by End Use, 2017-2032
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 01: Global Market Value (US$ Mn) by Product Type, 2022-2032
Figure 02: Global Market Value (US$ Mn) by Patient, 2022-2032
Figure 03: Global Market Value (US$ Mn) by End Use, 2022-2032
Figure 04: Global Market Value (US$ Mn) by Region, 2022-2032
Figure 05: Global Market Value (US$ Mn) Analysis by Region, 2017-2032
Figure 06: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 07: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 08: Global Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 09: Global Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 10: Global Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 11: Global Market Value (US$ Mn) Analysis by Patient, 2017-2032
Figure 12: Global Market Value Share (%) and BPS Analysis by Patient, 2022-2032
Figure 13: Global Market Y-o-Y Growth (%) Projections by Patient, 2022-2032
Figure 14: Global Market Value (US$ Mn) Analysis by End Use, 2017-2032
Figure 15: Global Market Value Share (%) and BPS Analysis by End Use, 2022-2032
Figure 16: Global Market Y-o-Y Growth (%) Projections by End Use, 2022-2032
Figure 17: Global Market Attractiveness by Product Type, 2022-2032
Figure 18: Global Market Attractiveness by Patient, 2022-2032
Figure 19: Global Market Attractiveness by End Use, 2022-2032
Figure 20: Global Market Attractiveness by Region, 2022-2032
Figure 21: North America Market Value (US$ Mn) by Product Type, 2022-2032
Figure 22: North America Market Value (US$ Mn) by Patient, 2022-2032
Figure 23: North America Market Value (US$ Mn) by End Use, 2022-2032
Figure 24: North America Market Value (US$ Mn) by Country, 2022-2032
Figure 25: North America Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 28: North America Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 29: North America Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 30: North America Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 31: North America Market Value (US$ Mn) Analysis by Patient, 2017-2032
Figure 32: North America Market Value Share (%) and BPS Analysis by Patient, 2022-2032
Figure 33: North America Market Y-o-Y Growth (%) Projections by Patient, 2022-2032
Figure 34: North America Market Value (US$ Mn) Analysis by End Use, 2017-2032
Figure 35: North America Market Value Share (%) and BPS Analysis by End Use, 2022-2032
Figure 36: North America Market Y-o-Y Growth (%) Projections by End Use, 2022-2032
Figure 37: North America Market Attractiveness by Product Type, 2022-2032
Figure 38: North America Market Attractiveness by Patient, 2022-2032
Figure 39: North America Market Attractiveness by End Use, 2022-2032
Figure 40: North America Market Attractiveness by Country, 2022-2032
Figure 41: Latin America Market Value (US$ Mn) by Product Type, 2022-2032
Figure 42: Latin America Market Value (US$ Mn) by Patient, 2022-2032
Figure 43: Latin America Market Value (US$ Mn) by End Use, 2022-2032
Figure 44: Latin America Market Value (US$ Mn) by Country, 2022-2032
Figure 45: Latin America Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 48: Latin America Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 49: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 51: Latin America Market Value (US$ Mn) Analysis by Patient, 2017-2032
Figure 52: Latin America Market Value Share (%) and BPS Analysis by Patient, 2022-2032
Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Patient, 2022-2032
Figure 54: Latin America Market Value (US$ Mn) Analysis by End Use, 2017-2032
Figure 55: Latin America Market Value Share (%) and BPS Analysis by End Use, 2022-2032
Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End Use, 2022-2032
Figure 57: Latin America Market Attractiveness by Product Type, 2022-2032
Figure 58: Latin America Market Attractiveness by Patient, 2022-2032
Figure 59: Latin America Market Attractiveness by End Use, 2022-2032
Figure 60: Latin America Market Attractiveness by Country, 2022-2032
Figure 61: Europe Market Value (US$ Mn) by Product Type, 2022-2032
Figure 62: Europe Market Value (US$ Mn) by Patient, 2022-2032
Figure 63: Europe Market Value (US$ Mn) by End Use, 2022-2032
Figure 64: Europe Market Value (US$ Mn) by Country, 2022-2032
Figure 65: Europe Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 68: Europe Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 69: Europe Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 70: Europe Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 71: Europe Market Value (US$ Mn) Analysis by Patient, 2017-2032
Figure 72: Europe Market Value Share (%) and BPS Analysis by Patient, 2022-2032
Figure 73: Europe Market Y-o-Y Growth (%) Projections by Patient, 2022-2032
Figure 74: Europe Market Value (US$ Mn) Analysis by End Use, 2017-2032
Figure 75: Europe Market Value Share (%) and BPS Analysis by End Use, 2022-2032
Figure 76: Europe Market Y-o-Y Growth (%) Projections by End Use, 2022-2032
Figure 77: Europe Market Attractiveness by Product Type, 2022-2032
Figure 78: Europe Market Attractiveness by Patient, 2022-2032
Figure 79: Europe Market Attractiveness by End Use, 2022-2032
Figure 80: Europe Market Attractiveness by Country, 2022-2032
Figure 81: Asia Pacific Market Value (US$ Mn) by Product Type, 2022-2032
Figure 82: Asia Pacific Market Value (US$ Mn) by Patient, 2022-2032
Figure 83: Asia Pacific Market Value (US$ Mn) by End Use, 2022-2032
Figure 84: Asia Pacific Market Value (US$ Mn) by Country, 2022-2032
Figure 85: Asia Pacific Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 86: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 87: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 88: Asia Pacific Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 89: Asia Pacific Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 90: Asia Pacific Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 91: Asia Pacific Market Value (US$ Mn) Analysis by Patient, 2017-2032
Figure 92: Asia Pacific Market Value Share (%) and BPS Analysis by Patient, 2022-2032
Figure 93: Asia Pacific Market Y-o-Y Growth (%) Projections by Patient, 2022-2032
Figure 94: Asia Pacific Market Value (US$ Mn) Analysis by End Use, 2017-2032
Figure 95: Asia Pacific Market Value Share (%) and BPS Analysis by End Use, 2022-2032
Figure 96: Asia Pacific Market Y-o-Y Growth (%) Projections by End Use, 2022-2032
Figure 97: Asia Pacific Market Attractiveness by Product Type, 2022-2032
Figure 98: Asia Pacific Market Attractiveness by Patient, 2022-2032
Figure 99: Asia Pacific Market Attractiveness by End Use, 2022-2032
Figure 100: Asia Pacific Market Attractiveness by Country, 2022-2032
Figure 101: MEA Market Value (US$ Mn) by Product Type, 2022-2032
Figure 102: MEA Market Value (US$ Mn) by Patient, 2022-2032
Figure 103: MEA Market Value (US$ Mn) by End Use, 2022-2032
Figure 104: MEA Market Value (US$ Mn) by Country, 2022-2032
Figure 105: MEA Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 106: MEA Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 107: MEA Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 108: MEA Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 109: MEA Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 110: MEA Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 111: MEA Market Value (US$ Mn) Analysis by Patient, 2017-2032
Figure 112: MEA Market Value Share (%) and BPS Analysis by Patient, 2022-2032
Figure 113: MEA Market Y-o-Y Growth (%) Projections by Patient, 2022-2032
Figure 114: MEA Market Value (US$ Mn) Analysis by End Use, 2017-2032
Figure 115: MEA Market Value Share (%) and BPS Analysis by End Use, 2022-2032
Figure 116: MEA Market Y-o-Y Growth (%) Projections by End Use, 2022-2032
Figure 117: MEA Market Attractiveness by Product Type, 2022-2032
Figure 118: MEA Market Attractiveness by Patient, 2022-2032
Figure 119: MEA Market Attractiveness by End Use, 2022-2032
Figure 120: MEA Market Attractiveness by Country, 2022-2032
